BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 94.00
-1.30 (-1.36%)
At close: Mar 6, 2026
BIONET Market Cap
BIONET has a market cap or net worth of 4.73 billion as of March 6, 2026. Its market cap has increased by 7.78% in one year.
Market Cap
4.73B
Enterprise Value
4.31B
Revenue
1.22B
Ranking
n/a
PE Ratio
68.08
Stock Price
94.00
Market Cap Chart
Since November 3, 2008, BIONET's market cap has increased from 1.14B to 4.73B, an increase of 313.51%. That is a compound annual growth rate of 8.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.73B | -9.18% |
| Dec 31, 2025 | 5.21B | 29.12% |
| Dec 31, 2024 | 4.03B | 47.30% |
| Dec 29, 2023 | 2.74B | 32.70% |
| Dec 30, 2022 | 2.06B | 9.73% |
| Dec 30, 2021 | 1.88B | -2.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 259.07B |
| Caliway Biopharmaceuticals | 216.22B |
| Heron Neutron Medical | 73.71B |
| Lotus Pharmaceutical | 70.48B |
| OBI Pharma | 5.23B |
| Pharmosa Biopharm | 5.23B |
| UnicoCell Biomed | 5.09B |
| SciVision Biotech | 5.06B |